Tuesday, November 05, 2024
Advertisement
  1. You Are At:
  2. News
  3. India
  4. COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

COVID-19 nasal vaccine launch: The vaccine is still not available on CoWin. According to the statement issued by the company, iNCOVACC® i is priced at Rs 800 for private markets and priced at Rs 325 for supplies to the government of India and State Governments.

Edited By: Sheenu Sharma New Delhi Updated on: January 26, 2023 0:01 IST
COVID19 nasal vaccine launch, nasal vaccine bharat biotech, nasal vaccine name, nasal vaccine booste
Image Source : BHARAT BIOTECH COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st Made-in-India nasal vaccine today.

COVID-19 nasal vaccine launch: Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday (January 26), official sources said.

According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® (BBV154) as a booster dose in the country.Earlier this month, Bharat Biotech received approval from the Central Drugs Standard Control Organization (CDSCO) for the use of heterologous booster doses of iNCOVACC®.

The vaccine is still not available on CoWin. According to the statement issued by the company, iNCOVACC® i is priced at Rs 800 for private markets and priced at Rs 325 for supplies to the government of India and State Governments."iNCOVACC® is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion-stabilized SARS-CoV-2 spike protein. This vaccine candidate was evaluated in phases I, II and III clinical trials with successful results. iNCOVACC® has been specifically formulated to allow intranasal delivery through nasal drops. The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries." the statement read.

Dr Krishna Ella, Executive Chairman said; "We have achieved the goals we set for ourselves during this pandemic. We have developed COVAXIN® and iNCOVACC®, two COVID vaccines from two different platforms, with two different delivery systems. The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics. We thank the Ministry of Health, CDSCO, Dept of Biotechnology, Govt of India, Technology Development Board, and Washington University, St Louis, for their support and guidance."

As a needleless vaccination, Bharat Biotech's iNCOVACC® will be India's first such booster dose.On the occasion of the launch, the Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr. Jitendra Singh, Dr Krishna Ella, Executive Chairman , Bharat Biotech and Suchitra Ellla, Joint Managing Director, Bharat Biotech will also be present. 

(With ANI inputs)

ALSO READ: Nasal swab can provide early warning of emerging viruses? Here's what the research says

ALSO READ: Bharat Biotech's nasal vaccine for Covid to cost Rs 800 for private hospitals, Rs 325 for govts

Advertisement

Read all the Breaking News Live on indiatvnews.com and Get Latest English News & Updates from India

Advertisement
Advertisement
Advertisement
Advertisement